Reddit Posts
BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model
#afterhours #watchlist 19/01 $CSPR - Casper Sleep gains after shareholders approve sale to Durational, $QTRX - no news, $SILK -no news... Also check afterhours runners and low float stocks in my app!
$QTRX I bought last monday are starting to move nicely <3
Mentions
Quanterix Corp (QTRX) - Defensible IP, massive TAM, well-capitalized balance sheet, and strong management team.
QTRX through the roof today
my current holdings ordered by position size (feel free to provide me with you input): 1. $SMCI 2. $NET 3. $ENVX 4. $S (senteniel one) 5. $PTLO 6. $QTRX 7. $TLT
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: QH SONM CNFR CVLY FUSN PSTX QTRX. Message /u/zjz if they're above 500 million-ish market cap and not related to crypto/pennies/OTC.
Thoughts on QTRX? Huge fan btw lol
Why do I get downvotes? Only GTHX is actually a Biotec, but for sure the most risky one out of the 5. ALLT is Cybersec with big backlog of projects for 2023 (Listen to last earning calls). MTBC is small Healthcare saas software provider with big amount of debt (Preferred shares) therefore the low multiples, but in my opinion they showed in the last quarters that they can manage (listen to the last 2 earning calls). QTRX and MXCT are device and consumable suppliers for Biotec and Big Pharma. They are not profitable yet but both have a big amount of cash on the balance sheet and are steady growing revenues and have major upcoming catalysts. QTRX developments build on: § FDA Breakthrough Device designation for plasma test for multiple sclerosis (MS). § FDA Breakthrough Device status for pTau-181 blood test as an aid in diagnostic evaluation of Alzheimer’s Disease (AD). Listen to their last earnings call to get a better feeling. MXCT upcoming catalysts: One of their customers (for example: Allogene, Crispr, Editas, Beam check out their latest [company presentation](https://investors.maxcyte.com/static-files/fa2fec9f-e124-452a-a0d1-305d4743dfd3) for the full list) makes progress. Next upcoming is probably the start of phase 2 trial of ALLO-501A.
Omg only large caps, let me change that: ALLT, QTRX, MTCB, MXCT, GTHX I like them because in my opinion they are all cheap at the moment
All across healthcare spectrum: ABT CI HZNP QTRX FLGT TAK MRK
DNN, DNA, QTRX, FB, ENVX DNN has a lot of exposure as a stock despite having run up a great deal over the past year. It's one of the safer bets in terms of single U companies. If U explodes overall, I think a smaller cap will go up a lot more, but DNN has a stronger support if things don't go perfectly. DNA will capture all of the growth as biopharma gets bigger and bigger. Simple as that. QTRX speculative biotechnology in a growing field. No reason in particular that I'd pick this for 2022 other than "this could be the year". I think long term they will explode either way. ENVX has the soft competitive edge (location, leadership, timing). Biggest threat is the tech not being as good as expected.
#Ban Bet Lost /u/phantomofthej (0/1) made a bet that QTRX would go to 55.0 when it was 48.0 and it did not, so they were banned for a week.
Any significant change to volume and [QTRX](https://www.reddit.com/r/wallstreetbets/comments/q7338i/qtrx_the_little_biotech_that_could/?utm_source=share&utm_medium=ios_app&utm_name=iossmf) goes parabolic
QTRX just keeps rippin’ on low volume lmao
it’s honestly fuk’d how low volume is on QTRX
They have a number of different assays that are offered for a broad range of therapeutic uses. There top competitors are companies like Olink, Inflazome, Bard1, and LaboCorp (not sure if any of them offer this particular technology) I looked into other companies that offer pTau-181 assays- I only found a few: - Fujirebio- not publicly traded and - ThermoFisher- which boasts a MC of $226.2 B [Here is more info on QTRX’s pTau-181 blood test](https://www.quanterix.com/simoa-assay-kits/p-tau-181/), but I think that they’re particularly attractive because of their low float, and they’re currently undervalued.
Nah, [QTRX](https://www.reddit.com/r/wallstreetbets/comments/q7338i/qtrx_the_little_biotech_that_could/?utm_source=share&utm_medium=ios_app&utm_name=iossmf)
If you aren’t long QTRX, you either a) hate money or b) are 🅱️etarded
Did you not see QTRX? They received breakthrough device designation from the US Food and Drug Administration for the company's phospho-Tau 181 blood test for Alzheimer's disease. Currently trading on low volume, but up ~16%. Bear in mind, they have a public float of only 34 M
Ban Bet Created --- **/u/phantomofthej** bet **QTRX** goes to **55.0** in **1 week**
And today the stock is tanking beacause QTRX said that it did not interpret the data or prepere the charts ,but Cassava never stated that, just said that it was \*generated\* by them which is true.
QTRX released a statement distancing themselves from the dumpster fire.
QTRX not wasting any time trying to distance themselves from the SAVA dumpster fire: https://www.businesswire.com/news/home/20210827005218/en/Quanterix-Releases-Statement
No one disagrees with that. But which stocks? Apple, Amazon, Google? Teladoc? Could former buy out latter? What about the actual drugs and treatments? CRSPR, biosimulation like SDGR. proteonomics like QTRX?
Why? Speculative biomed always going to be speculative. But aside from that, there are loads of companies like HZNP, SDGR, FLGT, ABCL, QTRX, EBS, ABCL, ARWR that have much more understandable and diversified businesses.
If you want an actual decent long term stock, put some money in QTRX. Look up the company and what they do and thank me in the years to come when you own your lambo. I am primate not financial consultation
NSTG QTRX SEER TXG EDIT NKTX FATE - Not all pure "genomics" but in the space.
NSTG QTRX SEER TXG EDIT NKTX FATE - Not all pure "genomics" but in the space.